1123-55-3

Usage

Uses

Used in Pharmaceutical Industry:
7-Benzothiazolamine (9CI) is used as an active pharmaceutical ingredient for its antimicrobial, antifungal, and anti-inflammatory properties. It is employed in the development of drugs targeting various infections and inflammatory conditions.
Used in Agricultural Industry:
In agriculture, 7-Benzothiazolamine (9CI) is used as a bioactive compound for its potential applications in controlling plant pathogens and pests, thereby contributing to crop protection and yield enhancement.
Used in Research and Development:
7-Benzothiazolamine (9CI) is used as a fluorescent dye in research applications, where its bright fluorescence under ultraviolet light aids in the visualization and analysis of biological samples and materials.
Used in Industrial Applications:
In the industrial sector, 7-Benzothiazolamine (9CI) is utilized as a fluorescent marker in various processes, including quality control, product inspection, and safety testing, due to its distinctive fluorescent properties.

InChI:InChI=1/C7H6N2S/c8-5-2-1-3-6-7(5)10-4-9-6/h1-4H,8H2

Upstream product

• 3970-41-0 2-chloro-3-nitroaniline 
• 149-30-4 2-Mercaptobenzothiazole 
• 95-16-9 1,3-Benzothiazole 
• 2942-05-4 7-nitrobenzothiazole 

Downstream Products

• 99512-75-1 7-Acetamino-benzthiazol 
• 41229-01-0 2-(benzothiazol-7-ylimino-methyl)-phenol 
• 41228-99-3 2-benzothiazol-7-ylazo-4-methoxy-phenol 
• 767-70-4 7-bromo-1,3-benzothiazole 
• 769-08-4 7-Amino-4-brombenzothiazol 
• 1298094-98-0 tetraphenyl (benzo[d]thiazol-7-ylamino)methylenediphosphonate 
• 1360448-91-4 1-(benzo[d]thiazol-7-yl)-3-phenylurea 
• 848679-07-2 N-(1,3-benzothiazol-7-yl)-N'-[4-(trifluoromethyl)benzyl]urea 
• 700-48-1 4,6-Dibrombenzothiazol 

Relevant academic research and scientific papers

Structure-activity relationships of N-phenyl-N′-benzothiazol-6-ylurea synthetic derivatives: Cytokinin-like activity and adventitious rooting enhancement

Some years ago we demonstrated the cytokinin-like activity of the synthetic N-phenyl-N′-benzothiazol-6-ylurea (PBU) and a relevant adventitious rooting adjuvant activity of symmetric urea derivatives devoid of any cytokinin- or auxin-like activity per se. Here we report the synthesis and the biological activity evaluation of nine symmetric or asymmetric ureas/thioureas, structurally related to PBU. None of them show cytokinin-like activity, while we demonstrate for the first time that PBU interacts with Arabidopsis cytokinin receptor CRE1/AHK4 in a heterologous bioassay system. Among the PBU derivatives, all the symmetric ureas/thioureas show an adventitious rooting adjuvant activity in various bioassays, confirming that this activity is strictly dependent on their chemical structure.

HETEROAROMATIC UREAS WHICH MODULATE THE FUNCTION OF THE VANILLOID-1 RECEPTOR (VR1)

Compounds of formula (I): are useful as therapeutic compounds, particularly in the treatment of pain and other conditions ameliorated by the modulation of the function of the vanilloid-1 receptor (VR1).

Synthesis and Reactions of Azido-benzothiazoles and -benzothiophens; Novel Thiazolobenzoxazoles and Dihydrothienobenzoxazoles

6-Azidobenzothiazole and its 2-methyl and 2-methylthio-derivatives were prepared from the corresponding amine and gave the thiazolobenzoxazoles (8)-(10), on thermolysis in a polyphosphoric-acetic acid mixture. 6,7-Dihydro-2-methylthienobenzoxazole 8,8-dioxide (12) was prepared similarly.An improved method of synthesis of 2-fluoro-6-nitrobenzothiazole is reported.